retatrutide not losing weight Side Effects Guide: 21 Proven Remedies That Work Effects of once-weekly subcutaneous retatrutide

Stay active Walking, cycling, swimming, or other regular physical activities promote healthy digestion and regular bowel movements

Cardiometabolic Research Beyond weight reduction, retatrutide's glucagon receptor component has attracted research interest for its cardiovascular effects

The AP densely co-expresses the GIPR and the GLP-1R, enabling it to directly receive and integrate dual hormonal signals from the systemic circulation

No other peptide in development has matched these numbers

Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonism: This component acts synergistically with GLP-1

Three studies did not show weight gain after treatment-induced weight loss, although each used different strategies or reported outcomes differently